Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

Cancer Stem Cells and Tumor Maintenance

Cancer Stem Cells and Tumor Maintenance

Tissue Renewal without Stem Cells

Tissue Renewal without Stem Cells

After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Risk Factors and a Prediction Model for Pain Recurrence After Pancreatic Stent Removal in Painful Chronic Pancreatitis.

Pancreas·2024

Same author

Prevalence and Distribution of Gastric Endoscopy Findings in Non-eosinophilic Esophagitis Eosinophilic Gastrointestinal Diseases: Influence of Atrophic Gastritis.

Internal medicine (Tokyo, Japan)·2024

Same author

AlphaMissense versus laboratory-based pathogenicity prediction of 13 novel missense <i>CPA1</i> variants from pancreatitis cases.

Gut·2024

Same author

Safety and effectiveness of additional triamcinolone acetonide with endoscopic radial incision and cutting for benign stenosis of the lower gastrointestinal tract: A pilot study.

DEN open·2024

Same author

Prospective multicenter surveillance study of branch-duct intraductal papillary mucinous neoplasm of the pancreas; risk of dual carcinogenesis.

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]·2024

Same author

Diagnosis of isolated hilar-/extrahepatic-type IgG-4-related sclerosing cholangitis can be increased by improved recognition of this condition-A Japanese multicenter analysis.

Journal of hepato-biliary-pancreatic sciences·2024

Search research articles

Related Experiment Video

Updated: Apr 12, 2026

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

[Pancreatic cancer stem cell].

Shin Hamada, Atsushi Masamune, Tooru Shimosegawa

Nihon Rinsho. Japanese Journal of Clinical Medicine

|May 20, 2015

Summary

This summary is machine-generated.

Pancreatic cancer stem cells drive poor prognosis and treatment resistance. Targeting these cells shows promise in experimental models, potentially improving patient outcomes.

More Related Videos

Isolation of Stem Cells from Human Pancreatic Cancer Xenografts

Isolation of Stem Cells from Human Pancreatic Cancer Xenografts

Published on: September 26, 2010

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

Related Experiment Videos

Last Updated: Apr 12, 2026

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

Isolation of Stem Cells from Human Pancreatic Cancer Xenografts

Isolation of Stem Cells from Human Pancreatic Cancer Xenografts

Published on: September 26, 2010

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

Area of Science:

Oncology
Cancer Biology

Context:

Pancreatic cancer exhibits dismal prognosis due to resistance to conventional therapies.
Metastasis and invasion limit surgical resection options.

Purpose:

To explore the role of cancer stem cells in pancreatic cancer.
To evaluate the potential of targeting cancer stem cells for improved therapeutic strategies.

Summary:

A subset of pancreatic cancer cells, known as cancer stem cells (CSCs), display resistance to chemotherapy and radiotherapy, possessing enhanced tumorigenicity and migratory capabilities.
Conventional therapies may inadvertently enrich CSC populations, highlighting the need for CSC-specific treatments.
Experimental models demonstrate that therapies targeting pancreatic CSCs can eliminate these cells and reduce cancer progression.

Impact:

Pancreatic cancer stem cell-targeting therapies offer a novel strategy to overcome treatment resistance.
Further clinical evaluation is required to validate the efficacy of these therapies in improving patient prognosis.